CD68 and Alzheimer disease: In addition, an increased intestinal Aβ load, AβPP, CD68, and p-Tau immunoreactivity was observed in AD patients, as well as in APP/PS1 mice, suggesting that the intestine of AD patients may mimic the brain, and induce inflammatory and immune changes relating to AβPP and Aβ pathology [86].